Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Pancreatic Polypeptide on Gastric Functions
NCT03854708Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Aug 2010
- Primary completion
- Mar 2011
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Pancreatic polypeptide in obesity (3 arms), sponsored by UZ Leuven. Primary endpoint: Intragastric pressure drop at 2 hours. Started Aug 2010; status: completed.
02
Drugs
Pancreatic polypeptide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03854708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03854708.